Hearing Aid Use Tied to 23% Lower Dementia Risk Specifically in Epilepsy Patients

Researchers from University Hospital Zurich and University of Liverpool matched hearing-aid users and non-users within the TriNetX database across multiple high-risk subgroups. Only the epilepsy cohort exhibited a consistent signal: absolute risk fell 2.7 percentage points over five years, yielding a number-needed-to-treat of 37. No comparable associations appeared in stroke, diabetes, heart failure or osteoarthritis strata. The specificity suggests that epilepsy-related reductions in cognitive reserve amplify the impact of correcting sensory deprivation, a pattern supported by prior observational work linking temporal-lobe epilepsy to accelerated hippocampal atrophy (Lancet Neurology 2022). Routine audiometry during epilepsy clinic visits could therefore function as a low-cost, reversible adjunct to existing dementia-prevention strategies. Confirmation will require prospective trials that capture seizure frequency, medication burden and objective audiometric thresholds as covariates.